• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A Combination of Trimethoprim-sulfamethoxazole and Ceftazidime Showed Good In Vitro Activity against .甲氧苄啶-磺胺甲恶唑与头孢他啶联合使用对……显示出良好的体外活性。
Malays J Med Sci. 2017 Mar;24(2):21-27. doi: 10.21315/mjms2017.24.2.3. Epub 2017 Apr 14.
2
Comparison of different antimicrobial susceptibility testing methods for Stenotrophomonas maltophilia and results of synergy testing.嗜麦芽寡养单胞菌不同抗菌药物敏感性检测方法的比较及协同作用研究结果。
J Infect Chemother. 2010 Oct;16(5):322-8. doi: 10.1007/s10156-010-0068-2. Epub 2010 May 7.
3
Susceptibility of Stenotrophomonas maltophilia clinical strains in China to antimicrobial combinations.中国嗜麦芽窄食单胞菌临床菌株对抗菌药物联合使用的敏感性
J Chemother. 2014 Oct;26(5):282-6. doi: 10.1179/1973947814Y.0000000168. Epub 2014 Mar 4.
4
In vitro activities of antimicrobial combinations against clinical isolates of Stenotrophomonas maltophilia.抗菌药物组合对嗜麦芽窄食单胞菌临床分离株的体外活性
J Formos Med Assoc. 2002 Jul;101(7):495-501.
5
In vitro susceptibilities of Stenotrophomonas maltophilia isolates to antimicrobial agents commonly used for related infections: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2004-2020.嗜麦芽窄食单胞菌分离株对相关感染常用抗菌药物的体外药敏结果:来自 2004-2020 年抗菌药物测试领导和监测(ATLAS)计划的数据。
Int J Antimicrob Agents. 2023 Aug;62(2):106878. doi: 10.1016/j.ijantimicag.2023.106878. Epub 2023 Jun 5.
6
Emergence of concurrent levofloxacin- and trimethoprim/sulfamethoxazole-resistant Stenotrophomonas maltophilia: Risk factors and antimicrobial sensitivity pattern analysis from a single medical center in Taiwan.嗜麦芽寡养单胞菌同时耐左氧氟沙星和复方磺胺甲噁唑的出现:来自台湾单一医疗中心的危险因素和抗菌药物敏感性分析。
J Microbiol Immunol Infect. 2022 Feb;55(1):107-113. doi: 10.1016/j.jmii.2020.12.012. Epub 2021 Jan 13.
7
Characterization of Phenotypic and Genotypic Diversity of Strains Isolated From Selected Hospitals in Iran.伊朗部分医院分离菌株的表型和基因型多样性特征分析
Front Microbiol. 2019 May 29;10:1191. doi: 10.3389/fmicb.2019.01191. eCollection 2019.
8
A multicenter surveillance of antimicrobial resistance on Stenotrophomonas maltophilia in Taiwan.台湾嗜麦芽寡养单胞菌的抗微生物药物耐药性多中心监测。
J Microbiol Immunol Infect. 2012 Apr;45(2):120-6. doi: 10.1016/j.jmii.2011.09.028. Epub 2011 Dec 11.
9
Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments.评估体外时间杀菌实验中复方新诺明/磺胺甲恶唑(SXT)、米诺环素、替加环素、莫西沙星和头孢他啶单独及联合使用对 SXT 敏感和 SXT 耐药嗜麦芽窄食单胞菌的效果。
PLoS One. 2016 Mar 21;11(3):e0152132. doi: 10.1371/journal.pone.0152132. eCollection 2016.
10
Activity of Potential Alternative Treatment Agents for Stenotrophomonas maltophilia Isolates Nonsusceptible to Levofloxacin and/or Trimethoprim-Sulfamethoxazole.潜在替代治疗剂对左氧氟沙星和/或复方磺胺甲噁唑不敏感的嗜麦芽窄食单胞菌分离株的活性。
J Clin Microbiol. 2020 Jan 28;58(2). doi: 10.1128/JCM.01603-19.

引用本文的文献

1
Global mapping of antibiotic resistance rates among clinical isolates of Stenotrophomonas maltophilia: a systematic review and meta-analysis.全球临床分离嗜麦芽寡养单胞菌耐药率的地图绘制:系统评价和荟萃分析。
Ann Clin Microbiol Antimicrob. 2024 Mar 19;23(1):26. doi: 10.1186/s12941-024-00685-4.
2
Global prevalence and antibiotic resistance in clinical isolates of : a systematic review and meta-analysis.全球临床分离株中的患病率及抗生素耐药性:一项系统评价和荟萃分析。
Front Med (Lausanne). 2023 May 5;10:1163439. doi: 10.3389/fmed.2023.1163439. eCollection 2023.
3
Bactericidal Activity of Ceragenin in Combination with Ceftazidime, Levofloxacin, Co-Trimoxazole, and Colistin against the Opportunistic Pathogen .鲨肌肽与头孢他啶、左氧氟沙星、复方新诺明和黏菌素联合使用对机会致病菌的杀菌活性
Pathogens. 2022 May 26;11(6):621. doi: 10.3390/pathogens11060621.
4
Stenotrophomonas maltophilia: An emerging opportunistic nosocomial pathogen in a tertiary care hospital in Al Batinah North Governorate, Oman.嗜麦芽寡养单胞菌:阿曼北部巴提奈省一家三级护理医院中一种新兴的机会性医院病原体。
Sultan Qaboos Univ Med J. 2021 Feb;21(1):e66-e71. doi: 10.18295/squmj.2021.21.01.009. Epub 2021 Mar 15.
5
Involvement of the RND efflux pump transporter SmeH in the acquisition of resistance to ceftazidime in Stenotrophomonas maltophilia.铜绿假单胞菌中 RND 外排泵转运蛋白 SmeH 参与头孢他啶耐药性的获得。
Sci Rep. 2019 Mar 20;9(1):4917. doi: 10.1038/s41598-019-41308-9.
6
Severe hepatic abscess: Conservative treatment of multi-organ infection by Stenotrophomonas maltophilia. A case report.严重肝脓肿:嗜麦芽窄食单胞菌引起多器官感染的保守治疗。病例报告。
Ann Med Surg (Lond). 2018 Sep 6;34:62-65. doi: 10.1016/j.amsu.2018.09.001. eCollection 2018 Oct.

本文引用的文献

1
Stenotrophomonas maltophilia bloodstream infection in patients with hematologic malignancies: a retrospective study and in vitro activities of antimicrobial combinations.嗜麦芽窄食单胞菌血流感染在血液系统恶性肿瘤患者中的回顾性研究及抗菌药物联合的体外活性
BMC Infect Dis. 2015 Feb 18;15:69. doi: 10.1186/s12879-015-0801-7.
2
Antimicrobial susceptibility of stenotrophomonas maltophilia isolates from Korea, and the activity of antimicrobial combinations against the isolates.韩国嗜麦芽寡养单胞菌分离株的抗菌药敏性及抗菌药物组合对分离株的活性。
J Korean Med Sci. 2013 Jan;28(1):62-6. doi: 10.3346/jkms.2013.28.1.62. Epub 2013 Jan 8.
3
Stenotrophomonas maltophilia infections in a general hospital: patient characteristics, antimicrobial susceptibility, and treatment outcome.嗜麦芽寡养单胞菌感染在综合医院的特征:患者特征、抗菌药物敏感性和治疗结果。
PLoS One. 2012;7(5):e37375. doi: 10.1371/journal.pone.0037375. Epub 2012 May 18.
4
Comparison of different antimicrobial susceptibility testing methods for Stenotrophomonas maltophilia and results of synergy testing.嗜麦芽寡养单胞菌不同抗菌药物敏感性检测方法的比较及协同作用研究结果。
J Infect Chemother. 2010 Oct;16(5):322-8. doi: 10.1007/s10156-010-0068-2. Epub 2010 May 7.
5
Antimicrobial susceptibilities of a worldwide collection of Stenotrophomonas maltophilia isolates tested against tigecycline and agents commonly used for S. maltophilia infections.对替加环素和常用于治疗嗜麦芽寡养单胞菌感染的药物进行测试的嗜麦芽寡养单胞菌分离株的全球耐药性。
Antimicrob Agents Chemother. 2010 Jun;54(6):2735-7. doi: 10.1128/AAC.01774-09. Epub 2010 Apr 5.
6
Stenotrophomonas maltophilia: an emerging opportunist human pathogen.嗜麦芽窄食单胞菌:一种新兴的机会性人类病原体。
Lancet Infect Dis. 2009 May;9(5):312-23. doi: 10.1016/S1473-3099(09)70083-0.
7
Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review.除复方新诺明外嗜麦芽窄食单胞菌感染的治疗选择:一项系统评价
J Antimicrob Chemother. 2008 Nov;62(5):889-94. doi: 10.1093/jac/dkn301. Epub 2008 Jul 28.
8
Antimicrobial therapy for Stenotrophomonas maltophilia infections.嗜麦芽窄食单胞菌感染的抗菌治疗。
Eur J Clin Microbiol Infect Dis. 2007 Apr;26(4):229-37. doi: 10.1007/s10096-007-0279-3.
9
In vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii and Stenotrophomonas maltophilia.替加环素对鲍曼不动杆菌和嗜麦芽窄食单胞菌临床分离株的体外活性。
J Antimicrob Chemother. 2007 Mar;59(3):583-5. doi: 10.1093/jac/dkl496. Epub 2007 Jan 9.
10
Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997-2004.1997 - 2004年无传统感染危险因素的癌症患者嗜麦芽窄食单胞菌肺炎
Eur J Clin Microbiol Infect Dis. 2007 Jan;26(1):13-20. doi: 10.1007/s10096-006-0243-7.

甲氧苄啶-磺胺甲恶唑与头孢他啶联合使用对……显示出良好的体外活性。

A Combination of Trimethoprim-sulfamethoxazole and Ceftazidime Showed Good In Vitro Activity against .

作者信息

Ismail Nabilah, Zam Zarifah, Hassan Siti Asma, Rahman Zaidah Abdul

机构信息

Department of Medical Microbiology and Parasitology, School of Medical Sciences, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia.

Hospital Taiping, Jalan Taming Sari, 34000 Taiping, Perak, Malaysia.

出版信息

Malays J Med Sci. 2017 Mar;24(2):21-27. doi: 10.21315/mjms2017.24.2.3. Epub 2017 Apr 14.

DOI:10.21315/mjms2017.24.2.3
PMID:28894400
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5566058/
Abstract

BACKGROUND

has emerged as an important nosocomial pathogen, capable of causing a wide spectrum of infections. Treatment is difficult because it is resistant to many antimicrobial agents, thus reducing the treatment options. The aims of this study were to describe the antimicrobial susceptibility patterns and synergistic effect of selected antimicrobial combinations against isolates.

METHODS

This was a descriptive cross-sectional study undertaken in the Hospital Universiti Sains Malaysia from April 2011 to March 2012. isolated from various clinical specimens were included in the study. Antimicrobial susceptibility testing was done using the epsilometer test (E-test) and interpreted according to the guidelines of the Clinical and Laboratory Standards Institute. In the synergy test, the isolates were tested against six different antimicrobial combinations.

RESULTS

In total, 84 isolates were collected and analysed. According to the E-test, the antimicrobial susceptibility of trimethoprim-sulfamethoxazole (TMP-SMX), tigecycline, and ciprofloxacin was 100%, 91.1%, and 88.9% respectively. The antimicrobial combination of TMP-SMX and ceftazidime showed the highest synergistic effect.

CONCLUSION

TMP-SMX remains the antimicrobial of choice to treat infection. TMP-SMX and ceftazidime was the most effective combination in vitro.

摘要

背景

已成为一种重要的医院病原体,能够引起广泛的感染。由于它对许多抗菌药物耐药,治疗困难,从而减少了治疗选择。本研究的目的是描述所选抗菌药物组合对分离株的抗菌敏感性模式和协同效应。

方法

这是一项于2011年4月至2012年3月在马来西亚理科大学医院进行的描述性横断面研究。从各种临床标本中分离出的菌株纳入研究。使用E试验(E-test)进行抗菌药物敏感性测试,并根据临床和实验室标准研究所的指南进行解释。在协同试验中,对分离株进行六种不同抗菌药物组合的测试。

结果

总共收集并分析了84株分离株。根据E试验,甲氧苄啶-磺胺甲恶唑(TMP-SMX)、替加环素和环丙沙星的抗菌敏感性分别为100%、91.1%和88.9%。TMP-SMX与头孢他啶的抗菌组合显示出最高的协同效应。

结论

TMP-SMX仍然是治疗感染的首选抗菌药物。TMP-SMX和头孢他啶在体外是最有效的组合。